Capecitabine Impurity 2
 
		Product Description
CAT No.
				
									ALN-C003017								
				CAS No.
				
									NA								
				Mol. F.
				
									C9H8FN3O5								
				Mol. Wt.
				
									257.2								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : 4-Amino-5-fluoro-1-((3aR,4R,6aR)-2-oxotetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidin-2(1H)-one								
				
									Smiles : O=C1N=C(N)C(F)=CN1[C@H]2[C@@H]([C@@H](CO2)O3)OC3=O								
				
									Inchi : InChI=1S/C10H12FN3O6/c1-18-10(17)20-5-3-19-8(6(5)15)14-2-4(11)7(12)13-9(14)16/h2,5-6,8,15H,3H2,1H3,(H2,12,13,16)/t5-,6-,8-/m1/s1								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Design of experiments (DoE) - based enhanced quality by design approach to hydrolytic degradation kinetic study of capecitabine by eco-friendly stability indicating UV-visible spectrophotometry
									By Prajapati, Pintu; Patel, Radhika; Patel, Dilan; Shah, ShaileshnFrom American Journal of PharmTech Research (2020), 10(6), 115-133								
				Validated stability indicating HPLC method for estimation of capecitabine
									By Lalitha, K. V.; Raveendra Reddy, J.; Devanna, N. – From International Journal of Pharmaceutical Sciences and Research (2020), 11(11), 5651-5658 								
				RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)
									By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K. – From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            